uBriGene's breakthroughs at the 12th mRNA Health
November 12, 2024
uBriGene Biosciences is thrilled to showcase its cutting-edge RNA therapeutics at the 12th Annual International mRNA Health Conference, taking place from November 12-14, 2024. This premier event serves as a global platform for industry and academic leaders to explore the rapidly evolving science and business of mRNA medicines.
The conference, hosted virtually and on-site at the Hilton Boston Park Plaza Hotel, will bring together over 900 professionals from academic institutions, biotechnology firms, and pharmaceutical companies. Attendees will have the opportunity to engage in discussions on mRNA innovations through scientific presentations, networking sessions, and industry collaborations.
uBriGene will highlight its breakthrough capabilities in GMP mRNA-LNP manufacturing. Our robust platform integrates advanced in vitro transcription technology, offering end-to-end services from plasmid DNA template preparation to bulk mRNA production and mRNA-LNP formulation. With comprehensive GMP manufacturing solutions, including precise mRNA modifications, capping, and tailing, uBriGene ensures the highest quality and performance for therapeutic candidates. Additionally, we provide RNA-LNP screening, process development, stability testing, and regulatory support to accelerate the development of RNA therapeutics.
Join us at the conference to learn more about how uBriGene can help fast-track your RNA-based therapies. Meet our team at the event or contact one of our experts to explore how our GMP mRNA manufacturing services can support your clinical and commercial goals.
We look forward to connecting with you in Boston or online!